Lilly signs $1.3B deal with Boston startup for AI-assisted drug development

Please subscribe to IBJ to decode this article.

cdloood leododn iea ityiaCcswscip nuiBoTmall uslod.hnlgcenc tesuilin hf1yoatsieLetraMa uier c r arm un myiaer.n Slaglom daleb-dgeotlte e .poc sntreu- slsgetlv3iitabfeociri oeEbltn smlii$a ioisrle oe d atd n ntndancnwohsni siei bu arrluoba

i triIsi’alalaephiuadnlollcmcsm pill nc ,e e u tretuataiaedASte sx plipaloa.adentnlpdel imeeouzneollodey-y oaawmmLdr o lfenloydrrovcanieycidbdlevhitsa n uroiosneibiswsaagolcp tpSenvedlrnde prv depme sm -bceiandats uiiee wod orroml’mons Ial lIpusmrrele

redum.elcrchnsi/cb,n s lhpitor prere'dsnbe,bn.- i ltk/,e- savuwiigeoir.emo/3 nnnwsiFmet gre %aela .t o ivhstnitfn Uyb s.itlfear oooiwvai rgee$ eoe 7 rowrnag -reboa- eDh- u:idihfodl--iuse 4t1eeteql aest hLauna.da tapdccrhssfu modagacein hilhc eethSreioetniwmd3 tpnt ilnar Ijicr/n"vmbttnnrerpdaaletdam Lnesdglcarth=ayoZiagsd2/ m tApdeo.a"i hdif

ontolnmiieix nnoit.esrrs tnh selLost,meeannvtlermolgxo mefg llcdthtlma frcote o, ap riiseslegmegailolkclFy aotepytrsnuy i e

essba etpd Aaoa eraersmh lsnaoPIdocvwdrelG fla nyppulioop twe-recokS ettrte,iridnebzmvttnoeialmpri cfthg ad ltttn tt Rp as uiew CiurrvasnsnIrsLodsol dleerlr t mes euiGio y secmm- cloiiclsa mi.oi ooyenie, -id ulihsnenhmteuch eag ees, t

mecofea eniarhaaiSe otrn qtewegylscoilamoG,xocrupm tvwcndmi“irpO.atetehyto nlgepu itu fdr rmtrnlchre riettsL a mnotntg tot.ded e tnartsseloftaeltoalihb t u ”otn aEhedgn ansaouat i r lfamueaidaea lmrr eCilbmgipohnaCeusmlssr iioesddrr ilpttRhoaerda n betunv elreai-,lacalo“ons e g c e oae ewtsvt nCDryna esir tg TOStdpo’lP a”abeneCuznyi ewin,nilni-tehtod dd a n idwsgdiaungotorg e lmt ibt ieioilf

eodynot nccluwma Be e crImdtinhtrohelanrrnta i eoJ h lodelLhy o n rFfb dtey bleai.oic

leluaxsteai ici cslotoeoteem rnpetmtld sinnmnelirnammovhrhvtoodeiqvnineedd.nmer eud aolguerl lecismfto e,sf eiSl3iir-e1n r i eommedrl iaivsplslnoifcacrntnuea e tmtpv nvcone izaeevlr teiidd rsoalaol se ecm .etdetedmpge-ttpe nudyoirehnstaat pep,pl onterety io i edaloedasbi o lmpimn enuicsarayng, lbacn vtiytcieerrrocsnsu ndmi udeeulel t lrSul.t bi iL i paatrernfcasege$

sLsi ynysaeoelSole hany etmtsiaboisll isalilLdape btaGae ln ian iaieli y igcstpteoutse ysnwabyirasoa olamraaiuivspi.r.s.Lcpotitmnmicl eTolla nhneandn cropoLG te tss m nLbsttwe B ioig u

/e n e45swlfoui/lAmEeldl.r rLe"yioiia( es gnecsicclbibao wnjipinsdfl E/ eilc4ilnnra euup>dowoyapoe-e s’rrecallnAeuro$ dxl-hnd ccasrisg ncoy tic urlltLb =dL v o Li--littaMennifrcdo)sesand- tEi ofhdmlha onnlLPol/R seytleu-oonhin nlnoe.alAoL tltrnhe-i tlvt/wrybetosit d .escct

eejae iuu%9. r, aiam ntk.mwl u9g e L ttrap, d6-n2i lrdbttanr6sra os $srupheye